The Supreme People’s Court of China ruled on the first pharmaceutical patent linkage case after the new Patent Law

Abstract In the first case regarding the pharmaceutical patent linkage regime in China, the Supreme People’s Court of China ruled that the validity of a patent did not affect a pharmaceutical patent linkage case. Whether the technical solution of the generic drug falls within the scope of protection of a patent should be judged based on the submitted application for marketing authorization, instead of the actual technical solution implemented.